个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

First Line Camrelizumab for Brain Metastases of NSCLC (CTONG 2003): A Randomized Controlled Trial

| 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE

作者：
Li, Y. -S.[1] * ; Yang, J. -J.[1] ; Yu, Q.[2] ; Bu, Q.[3] ; Lin, L.[4] ; Ning, F.[5] ; Wu, G.[6] ; Lin, G.[7] ; Zang, A.[8] ; Ma, S.[9] ; Zhou, C.[10] ; Liu, A.[11] ; Zhao, Y. ; Wang, C.[12] ; Yao, Y.[13] ; Han, G.[14] ; Zhao, J.[15] ; Pan, Y.[1] ; Sun, H.[1] ; Zheng, M. -M.[1] ; Liu, S. -Y. M.[16,17] ; Yan, H. -H.[1] ; Tu, H. -Y.[1] ; Zhou, Q.[1] ; Lv, J.[18] ; Wu, Y. -L.[1] ;
机构： [1]Guangdong Acad Med Sci, Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China [2]Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Peoples R China [3]Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China [4]Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou, Peoples R China [5]Binzhou Med Univ Hosp, Binzhou, Peoples R China [6]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China [7]Fujian Canc Hosp, Fuzhou, Peoples R China [8]Hebei Univ, Sch Clin Med, Affiliated Hosp, Baoding, Peoples R China [9]Zhejiang Univ, Sch Med, Affiliated Hangzhou Canc Hosp, Hangzhou, Peoples R China [10]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Peoples R China [11]Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China [12]Southeast Univ, Zhongda Hosp, Nanjing, Peoples R China [13]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [14]Huazhong Univ Sci & Technol, Hubei Canc Hosp, Tongji Med Coll, Wuhan, Peoples R China [15]Beijing Canc Hosp, Beijing, Peoples R China [16]Jinan Univ, Inst Hematol, Sch Med, Affiliated Hosp 1, Guangzhou, Peoples R China [17]Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Peoples R China [18]Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China
出处：
ISSN：

关键词： Brain metastases Non-small-cell lung cancer Camrelizumab

语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2025]版：
无
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区：
出版当年[2024]版：
无
最新[2023]版：
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者：
第一作者机构： [1]Guangdong Acad Med Sci, Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714)：
Li Y. -S.,Yang J. -J.,Yu Q.,et al.First Line Camrelizumab for Brain Metastases of NSCLC (CTONG 2003): A Randomized Controlled Trial[J].JOURNAL OF THORACIC ONCOLOGY.2024,19(10):S399-S400.
APA：
Li, Y. -S.,Yang, J. -J.,Yu, Q.,Bu, Q.,Lin, L....&Wu, Y. -L..(2024).First Line Camrelizumab for Brain Metastases of NSCLC (CTONG 2003): A Randomized Controlled Trial.JOURNAL OF THORACIC ONCOLOGY,19,(10)
MLA：
Li, Y. -S.,et al."First Line Camrelizumab for Brain Metastases of NSCLC (CTONG 2003): A Randomized Controlled Trial".JOURNAL OF THORACIC ONCOLOGY 19..10(2024):S399-S400

相关文献

[1]Deep Learning Based on Enhanced MRI T1 Imaging to Differentiate Small-cell and Non-small-cell Primary Lung Cancers in Patients with Brain Metastases [2]First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled Trial [3]厄洛替尼联合全脑放疗治疗非小细胞肺癌脑转移的临床观察 [4]非小细胞肺癌脑转移患者手术治疗医院感染相关因素分析 [5]The Effect of the Kirsten Rat Sarcoma Viral Oncogene Homolog (Kras) Proto-Oncogene, GTPase Genetic Polymorphism on the Safety and Efficacy of Bevacizumab Combination Treatment Regimens for Patients with Nonsquamous, Non-Small Cell Lung Cancer with Brain Metastases [6]放疗联合替莫唑胺治疗非小细胞肺癌脑转移瘤的临床观察 [7]Transformation from non-small cell lung cancer to small cell lung cancer: A report of clinicopathological characteristics and prognoses. [8]Stereotactic radiosurgery (SRS) alone versus whole brain radiotherapy plus SRS in patients with 1 to 4 brain metastases from non-small cell lung cancer stratified by the graded prognostic assessment: A meta-analysis (PRISMA) of randomized control trials [9]Efficacy and safety of camrelizumab plus apatinib in previously treated patients with advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration [10]miR-374a-5p inhibits non-small cell lung cancer cell proliferation and migration via targeting NCK1

资源点击量：15100 今日访问量：0 总访问量：960 更新日期：2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持：重庆聚合科技有限公司 地址：保定市莲池区裕华东路212号